Journal Report

Medicinal Chemistry Research

Download PDF
Journal Information
Journal Title
Medicinal Chemistry Research
Publisher
Springer
ISSN
1054-2523
E-ISSN
1554-8120
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Small-molecule ferroptosis inducers and sensitizers in anticancer drug discovery: medicinal chemistry, structure–activity relationships, and translational perspectives
Aashik Malik, Md Arif Naseer, Mayank Yadav et al.
2026-10-24
DOI: 10.1007/s00044-026-03632-4
Azole chroman-4-one, tetralone and chromen-4-one derivatives: synthesis, Mycobacterium tuberculosis CYP121A1 enzyme inhibition and antimycobacterial activity
Jabril M. Abdali, Lama A. Alshabani, Alistair K. Brown et al.
2026-10-23
DOI: 10.1007/s00044-026-03631-5
Structure-based discovery of acridone alkaloids as disruptors of the HEG1–KRIT1 protein–protein interaction in cerebral cavernous malformation signaling
Emadeldin M. Kamel, May Bin-Jumah, Haifa E. Alfassam et al.
2026-10-13
DOI: 10.1007/s00044-026-03627-1
Coumarin scaffolds in breast cancer research: derivatives, hybrids, and therapeutic potential
Shagufta, Irshad Ahmad, Isha Khan et al.
2026-10-13
DOI: 10.1007/s00044-026-03629-z
Bicyclononane-2,8-bis(trifluoromethyl)quinoline hybrids: synthesis, antiplasmodial and antitrypanosomal activity
Johanna Dolensky, Werner Seebacher, Eva-Maria Pferschy-Wenzig et al.
2026-10-6
DOI: 10.1007/s00044-026-03628-0
Special issue of Medicinal Chemistry Research in honor of Dr. Kenneth A. Jacobson
Carola Gallo-Rodriguez, Juan Bautista Rodriguez, Pnina Fishman
2026-10 Vol. 35 Issue 10 Pages 1819-1820
DOI: 10.1007/s00044-026-03630-6
From danger to resolution: targeting purinergic signaling in CNS diseases
Camille Degryse, Kirti Gupta, Luc Buée et al.
2026-10 Vol. 35 Issue 10 Pages 2007-2027
DOI: 10.1007/s00044-026-03583-w
Vepdegestrant: the first FDA-approved oral PROTAC and a milestone in targeted protein degradation
Jeffrey Yang, Longqin Hu
2026-10-1
DOI: 10.1007/s00044-026-03622-6
Baxdrostat (Baxfendy®), a first-in-class aldosterone synthase inhibitor approved for adults with uncontrolled hypertension
Ahmed R. Ali, Longqin Hu
2026-9-29
DOI: 10.1007/s00044-026-03620-8
Design and biological evaluation of sulfonamide–chalcone hybrids with in vitro tumor-selective cytotoxicity against oral squamous cell carcinoma: SAR, QSAR, and in silico ADME studies
Gulsen Ozli, Hiroshi Sakagami, M. Fatih Polat et al.
2026-9-29
DOI: 10.1007/s00044-026-03624-4
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 30, 2026 18:32